Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Tiina Juntikka, Nea Malila, Tiina Ylöstalo, Minna Merikivi & Sirkku Jyrkkiö. (2020) Epidemiology of classic and nodular lymphocyte predominant hodgkin lymphoma in Finland in 1996–2015. Acta Oncologica 59:5, pages 574-581.
Read now
Read now
Lukas F. Ocias, Thomas S. Larsen, Hanne Vestergaard, Lone S. Friis, Niels Abildgaard & Henrik Frederiksen. (2016) Trends in hematological cancer in the elderly in Denmark, 1980–2012. Acta Oncologica 55:sup1, pages 98-107.
Read now
Read now
Maria Theresa Redaniel, Dianne Pulte & Mona Jeffreys. (2015) Survival disparities by age and country of diagnosis for patients with acute leukemia. Leukemia & Lymphoma 56:10, pages 2787-2792.
Read now
Read now
Hans H. Storm, Gerda Engholm, Timo Hakulinen, Laufey Tryggvadóttir, Åsa Klint, Mette Gislum, Anne Mette T. Kejs & Freddie Bray. (2010) Survival of patients diagnosed with cancer in the Nordic countries up to 1999–2003 followed to the end of 2006. A critical overview of the results. Acta Oncologica 49:5, pages 532-544.
Read now
Read now
Gerda Engholm, Mette Gislum, Freddie Bray & Timo Hakulinen. (2010) Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964–2003 followed up to the end of 2006. Material and methods. Acta Oncologica 49:5, pages 545-560.
Read now
Read now
Articles from other publishers (37)
Filip Tichanek, Asta Försti, Akseli Hemminki, Otto Hemminki & Kari Hemminki. (2023) Long-Term Periodic and Conditional Survival Trends in Prostate, Testicular, and Penile Cancers in the Nordic Countries, Marking Timing of Improvements. Cancers 15:17, pages 4261.
Crossref
Crossref
Frantisek Zitricky, Asta Försti, Akseli Hemminki, Otto Hemminki & Kari Hemminki. (2023) Conditional Survival in Prostate Cancer in the Nordic Countries Elucidates the Timing of Improvements. Cancers 15:16, pages 4132.
Crossref
Crossref
Frantisek Zitricky, Asta Försti, Akseli Hemminki & Kari Hemminki. (2023) Conditional survival in breast cancer up to 10 years in the Nordic countries. Cancer Medicine.
Crossref
Crossref
Filip Tichanek, Asta Försti, Otto Hemminki, Akseli Hemminki & Kari Hemminki. (2023) Survival, Incidence, and Mortality Trends in Female Cancers in the Nordic Countries. Obstetrics and Gynecology International 2023, pages 1-9.
Crossref
Crossref
Kari Hemminki, Janne Hemminki, Asta Försti & Amit Sud. (2023) Survival in hematological malignancies in the Nordic countries through a half century with correlation to treatment. Leukemia 37:4, pages 854-863.
Crossref
Crossref
Filip Tichanek, Asta Försti, Vaclav Liska, Akseli Hemminki & Kari Hemminki. (2023) Survival in Colon, Rectal and Small Intestinal Cancers in the Nordic Countries through a Half Century. Cancers 15:3, pages 991.
Crossref
Crossref
Kari Hemminki, Anna Kanerva, Asta Försti & Akseli Hemminki. (2022) Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment. BMC Cancer 22:1.
Crossref
Crossref
Kari Hemminki, Asta Försti, Otto Hemminki, Vaclav Liska & Akseli Hemminki. (2022) Long‐term incidence and survival trends in cancer of the gallbladder and extrahepatic bile ducts in Denmark, Finland, Norway and Sweden with etiological implications related to Thorotrast. International Journal of Cancer 151:2, pages 200-208.
Crossref
Crossref
Anni Koskinen, Otto Hemminki, Asta Försti & Kari Hemminki. (2022) Incidence and survival in laryngeal and lung cancers in Finland and Sweden through a half century. PLOS ONE 17:5, pages e0268922.
Crossref
Crossref
Nadav Ofshenko, Eyal Bercovich, Tania Mashiach, Michal Weiler-Sagie, Daniela Militianu & Eldad J. Dann. (2022) Reduction of the Vertebral Bone Mineral Density in Patients with Hodgkin Lymphoma Correlates with Their Age and the Treatment Regimen They Received. Cancers 14:3, pages 495.
Crossref
Crossref
Kari Hemminki, Asta Försti, Akseli Hemminki, Börje Ljungberg & Otto Hemminki. (2022) Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years. PLOS ONE 17:1, pages e0261124.
Crossref
Crossref
Makka Adam, Yonas Bekueretsion, Abdulaziz Abubeker, Fisihatsion Tadesse, Anna Kwiecinska, Rawleigh Howe, Beyene Petros, Mats Jerkeman & Amha Gebremedhin. (2021) Clinical Characteristics and Histopathological Patterns of Hodgkin Lymphoma and Treatment Outcomes at a Tertiary Cancer Center in Ethiopia. JCO Global Oncology:7, pages 277-288.
Crossref
Crossref
Kari Hemminki, Asta Försti, Tianhui Chen & Akseli Hemminki. (2021) Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden. BMC Cancer 21:1.
Crossref
Crossref
Kari Hemminki, Asta Försti & Markus Hansson. (2021) Incidence, mortality and survival in multiple myeloma compared to other hematopoietic neoplasms in Sweden up to year 2016. Scientific Reports 11:1.
Crossref
Crossref
Kari Hemminki, Asta Försti & Akseli Hemminki. (2021) Survival in colon and rectal cancers in Finland and Sweden through 50 years. BMJ Open Gastroenterology 8:1, pages e000644.
Crossref
Crossref
Kari Hemminki, Asta Försti, Akseli Hemminki, Börje Ljungberg & Otto Hemminki. (2021) Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden. PLOS ONE 16:6, pages e0253236.
Crossref
Crossref
Jesko Momotow, Sven Borchmann, Dennis A. Eichenauer, Andreas Engert & Stephanie Sasse. (2021) Hodgkin Lymphoma—Review on Pathogenesis, Diagnosis, Current and Future Treatment Approaches for Adult Patients. Journal of Clinical Medicine 10:5, pages 1125.
Crossref
Crossref
Sara Ekberg, Karin E. Smedby, Ingrid Glimelius, Herman Nilsson‐Ehle, Christina Goldkuhl, Catharina Lewerin, Mats Jerkeman & Sandra Eloranta. (2020) Trends in the prevalence, incidence and survival of non‐Hodgkin lymphoma subtypes during the 21st century – a Swedish lymphoma register study. British Journal of Haematology 189:6, pages 1083-1092.
Crossref
Crossref
Kasper Adelborg, Priscila Corraini, Bianka Darvalics, Henrik Frederiksen, Anne Ording, Erzsébet Horváth‐Puhó, Mikael Rørth & Henrik T. Sørensen. (2019) Risk of thromboembolic and bleeding outcomes following hematological cancers: A Danish population‐based cohort study. Journal of Thrombosis and Haemostasis 17:8, pages 1305-1318.
Crossref
Crossref
Bo Yang, Ruili Yu, Lili Cai, Bin Guo, Hongfei Chen, Haomin Zhang, Peifeng He & Xuechun Lu. (2018) Haploidentical versus matched donor stem cell transplantation for patients with hematological malignancies: a systemic review and meta-analysis. Bone Marrow Transplantation 54:1, pages 99-122.
Crossref
Crossref
Dianne Pulte, Janick Weberpals, Lina Jansen, Sabine Luttmann, Bernd Holleczek, Alice Nennecke, Meike Ressing, Alexander Katalinic, Hermann Brenner, Karla Geiss, Martin Meyer, Andrea Eberle, Sabine Luttmann, Roland Stabenow, Stefan Hentschel, Alice Nennecke, Joachim Kieschke, Eunice Sirri, Bernd Holleczek, Katharina Emrich, Hiltraud Kajüter, Volkmar Mattauch, Alexander Katalinic, Nora Eisemann, Benjamin Barnes, Klaus Kraywinkel, Hermann Brenner, Lina Jansen & Janick Weberpals. (2017) Survival for patients with rare haematologic malignancies: Changes in the early 21st century. European Journal of Cancer 84, pages 81-87.
Crossref
Crossref
Gustavo Kusminsky, Graciela Abriata, David Forman & Mónica S. Sierra. (2016) Hodgkin lymphoma burden in Central and South America. Cancer Epidemiology 44, pages S158-S167.
Crossref
Crossref
Morgane Mounier, Nadine Bossard, Laurent Remontet, Aurélien Belot, Pamela Minicozzi, Roberta De Angelis, Riccardo Capocaccia, Jean Iwaz, Alain Monnereau, Xavier Troussard, Milena Sant, Marc Maynadié & Roch Giorgi. (2015) Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5). The Lancet Haematology 2:11, pages e481-e491.
Crossref
Crossref
Volkan Turan & Kutluk Oktay. 2015. Cancer Treatment and the Ovary. Cancer Treatment and the Ovary
47
61
.
Roberto Pastor-Barriuso & Gonzalo López-Abente. (2014) Changes in period and cohort effects on haematological cancer mortality in Spain, 1952-2006. BMC Cancer 14:1.
Crossref
Crossref
Milena Ilic & Irena Ilic. (2014) Malignant Lymphatic and Hematopoietic Neoplasms Mortality in Serbia, 1991–2010: A Joinpoint Regression Analysis. PLoS ONE 9:10, pages e109379.
Crossref
Crossref
Dianne Pulte, Maria T. Redaniel, Lisa Lowry, Jenny Bird & Mona Jeffreys. (2014) Age disparities in survival from lymphoma and myeloma: a comparison between US and England. British Journal of Haematology 165:6, pages 824-831.
Crossref
Crossref
K. Innos, A. Baburin & T. Aareleid. (2014) Cancer patient survival in Estonia 1995–2009: Time trends and data quality. Cancer Epidemiology 38:3, pages 253-258.
Crossref
Crossref
Justo Lorenzo Bermejo, Eero Pukkala, Tom B. Johannesen, Jan Sundquist & Kari Hemminki. (2014) Age-time risk patterns of solid cancers in 60 901 non-Hodgkin lymphoma survivors from Finland, Norway and Sweden. British Journal of Haematology 164:5, pages 675-683.
Crossref
Crossref
Martin Bøgsted, Anders E. Bilgrau, Christopher P. Wardell, Uta Bertsch, Alexander Schmitz, Julie S. Bødker, Malene K. Kjeldsen, Hartmut Goldschmidt, Gareth J. Morgan, Karen Dybkaer & Hans E. Johnsen. (2013) Proof of the Concept to Use a Malignant B Cell Line Drug Screen Strategy for Identification and Weight of Melphalan Resistance Genes in Multiple Myeloma. PLoS ONE 8:12, pages e83252.
Crossref
Crossref
Alain Monnereau, Xavier Troussard, Aurélien Belot, Anne‐Valérie Guizard, Anne‐Sophie Woronoff, Simona Bara, Bénédicte Lapôtre‐Ledoux, Jean Iwaz, Brigitte Tretarre & Marc Maynadié. (2012) Unbiased estimates of long‐term net survival of hematological malignancy patients detailed by major subtypes in France. International Journal of Cancer 132:10, pages 2378-2387.
Crossref
Crossref
Giuliano Bedoschi & Kutluk Oktay. (2013) Current approach to fertility preservation by embryo cryopreservation. Fertility and Sterility 99:6, pages 1496-1502.
Crossref
Crossref
James W. Little, Donald A. Falace, Craig S. Miller & Nelson L. Rhodus. 2013. Little and Falace's Dental Management of the Medically Compromised Patient. Little and Falace's Dental Management of the Medically Compromised Patient
384
408
.
Kari Hemminki, Xiangdong Liu, Asta Försti, Jianguang Ji, Jan Sundquist & Kristina Sundquist. (2012) Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma. Journal of Hematology & Oncology 5:1.
Crossref
Crossref
Kirsten Tryde Schmidt & Claus Yding Andersen. (2012) Recommendations for fertility preservation in patients with lymphomas. Journal of Assisted Reproduction and Genetics 29:6, pages 473-477.
Crossref
Crossref
Hyeon Jin ParkEun-Hye ParkKyu-Won JungHyun-Joo KongYoung-Joo WonJoo Young LeeJong Hyung YoonByung-Kiu ParkHyewon LeeHyeon-Seok EomSohee Park. (2012) Statistics of hematologic malignancies in Korea: incidence, prevalence and survival rates from 1999 to 2008. The Korean Journal of Hematology 47:1, pages 28.
Crossref
Crossref
S.A.M. van de Schans, D.E. Issa, O. Visser, P. Nooijen, P.C. Huijgens, H.E. Karim-Kos, M.L.G. Janssen-Heijnen & J.W.W. Coebergh. (2012) Diverging trends in incidence and mortality, and improved survival of non-Hodgkin's lymphoma, in the Netherlands, 1989–2007. Annals of Oncology 23:1, pages 171-182.
Crossref
Crossref